Company / Working Capital per Share
IOVANCE BIOTHERAPEUTICS, INC. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.00
FY2025
5-year range
$1.00 / $2729.72
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#179 of 210
Health Care
What the data says
IOVANCE BIOTHERAPEUTICS, INC.'s working capital per share of $1.00 is lower than 85% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $1.00 in FY2025 to $4202.64 in FY2020.
Based on SEC 10-K filings.
1.00 in FY2025 with a 5-year CAGR of -81.2%.
Declined from $1.05 to $1.00 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -92.6%
- 5-Year CAGR
- -81.2%
- 10-Year CAGR
- -
Sector benchmark
-99.2% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 23.7% year-over-year.
- Ranks #179 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.00 | -23.7% |
| FY2024 | $1.31 | +24.2% |
| FY2023 | $1.05 | -100.0% |
| FY2022 | $2433.97 | -10.8% |
| FY2021 | $2729.72 | -35.0% |
| FY2020 | $4202.64 | +88.4% |
| FY2019 | $2231.12 | +35311.8% |
| FY2018 | $6.30 | +180.8% |
| FY2017 | $2.24 | -33.8% |
| FY2016 | $3.39 | +11.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026